Zynteglo

luspogene nepogene · Bluebird Bio (formerly bluebird bio) / its collaborators

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Zynteglo, covering 2021-02-17 to 2022-11-30. Get the full timeline:

Most recent: EMA Withdrawn: Zynteglo (autologous CD34+ cell enriched population that contains haematopoietic stem cells transduced with lentiviral vector encoding the βA-T87Q-globin gene) — bluebird bio (Netherlands) B.V.

See pricing